TransMedics Group, Inc. TMDX
Set alert
As of Nov 2, 10:54 AM ET
- YTD
- -44.14%
- 1 year
- -48.34%
- Open
- 66.47
- Prev close
- 65.99
- Mkt cap
- 2.35B
- Vol
- 136.94K
- Avg vol
- 837.49K
- EPS
- 3.86
- P/E
- 17.58
- Div yield
- 0.00%
More statistics
- Low
- 65.84
- High
- 68.00
- Forward P/E
- 29.35
- Beta
- 1.93
- Short ratio
- 11.14
- Inst. own
- 103.40%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 82.15
- 200-d avg
- 94.86
- 1y target
- 98.73
5D chart
Signals (105)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | Nov 2, 10:25 AM | 30 minutes ago |
| RSI: Overbought | Nov 2, 10:00 AM | 55 minutes ago |
| RSI: Overbought | Nov 2, 9:35 AM | 1 hour ago |
| RSI: Overbought | Oct 30, 3:50 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:10 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:05 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:55 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:35 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:35 PM | 2 days ago |
| RSI: Oversold | Oct 30, 2:15 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:10 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:35 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:20 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 12:25 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:15 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 10:50 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:45 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:45 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 10:30 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:15 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:15 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:05 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:05 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:00 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:00 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:35 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 9:35 AM | 3 days ago |
| SMA: Bearish | Oct 29, 3:55 PM | 3 days ago |
| RSI: Overbought | Oct 29, 3:35 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:10 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:50 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:25 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:20 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:20 PM | 3 days ago |
| RSI: Oversold | Oct 29, 2:05 PM | 3 days ago |
| RSI: Oversold | Oct 29, 1:35 PM | 3 days ago |
| RSI: Oversold | Oct 29, 12:45 PM | 3 days ago |
| SMA: Bearish | Oct 29, 11:30 AM | 4 days ago |
| SMA: Bullish | Oct 29, 11:20 AM | 4 days ago |
| MACD: Sell Signal | Oct 29, 10:50 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:45 AM | 4 days ago |
| SMA: Bullish | Oct 29, 10:10 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 4 days ago |
| SMA: Bullish | Oct 29, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 29, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:55 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:50 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:45 PM | 4 days ago |
| RSI: Oversold | Oct 28, 3:15 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:40 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:35 PM | 4 days ago |
| RSI: Oversold | Oct 28, 2:10 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:35 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:25 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 12:45 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:40 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:40 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:35 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:30 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:25 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:25 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:20 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:15 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:00 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:00 PM | 4 days ago |
| SMA: Bullish | Oct 28, 11:45 AM | 5 days ago |
| SMA: Bullish | Oct 28, 11:25 AM | 5 days ago |
| MACD: Buy Signal | Oct 28, 11:15 AM | 5 days ago |
| SMA: Bullish | Oct 28, 11:10 AM | 5 days ago |
| MACD: Sell Signal | Oct 28, 10:35 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:30 AM | 5 days ago |
| SMA: Bullish | Oct 28, 10:25 AM | 5 days ago |
| MACD: Buy Signal | Oct 28, 10:25 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:20 AM | 5 days ago |
| MACD: Sell Signal | Oct 28, 10:20 AM | 5 days ago |
| SMA: Bullish | Oct 28, 10:15 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:10 AM | 5 days ago |
| MACD: Buy Signal | Oct 28, 9:55 AM | 5 days ago |
| SMA: Bullish | Oct 28, 9:50 AM | 5 days ago |
| RSI: Oversold | Oct 28, 9:30 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 3:55 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 3:45 PM | 5 days ago |
| SMA: Bearish | Oct 27, 3:25 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:15 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:55 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:55 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 1:55 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:50 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:45 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:40 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 1:35 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:30 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:20 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:20 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:45 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:45 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:35 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:30 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:00 PM | 5 days ago |
| SMA: Bearish | Oct 27, 11:55 AM | 6 days ago |
| SMA: Bullish | Oct 27, 11:50 AM | 6 days ago |
| SMA: Bearish | Oct 27, 11:45 AM | 6 days ago |
| SMA: Bullish | Oct 27, 11:30 AM | 6 days ago |
| SMA: Bearish | Oct 27, 11:25 AM | 6 days ago |
| SMA: Bullish | Oct 27, 10:40 AM | 6 days ago |
News
18 hours ago businesswire.com
TMDX Investors Have Opportunity to Join TransMedics Group, Inc. Fraud Investigation with SBS Law
LOS ANGELES--(BUSINESS WIRE)---- $TMDX--TMDX Investors Have Opportunity to Join TransMedics Group, Inc. Fraud Investigation with SBS Law.
2 days ago prnewswire.com
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANDOVER, Mass., Oct. 30, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with…
3 days ago prnewswire.com
TransMedics to Present at Upcoming Investor Conferences
ANDOVER, Mass., Oct. 29, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with…
6 days ago globenewswire.com
TransMedics selects Gogo Galileo HDX for nationwide organ transport fleet
Reliable, high-performance connectivity will support time-critical transport and monitoring of donor organs for transplants aboard 22 Embraer Phenom 300E aircraft Reliable, high-performance…
-
2 weeks ago benzinga.com
Canaccord Genuity Maintains Buy on TransMedics Group, Lowers Price Target to $94
Canaccord Genuity analyst Jason Mills maintains TransMedics Group (NASDAQ:TMDX) with a Buy and lowers the price target from $95 to $94.
-
3 weeks ago benzinga.com
Barclays Initiates Coverage On TransMedics Group with Overweight Rating, Announces Price Target of $120
Barclays analyst Christopher Pasquale initiates coverage on TransMedics Group (NASDAQ:TMDX) with a Overweight rating and announces Price Target of $120.
-
1 month ago benzinga.com
TransMedics Group Appoints Fernando Araujo CFO, Effective Sept. 21; Reaffirms FY26 Revenue Range $737M - $757M
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), the global leader in portable warm perfusion for donor organs for transplantation, today announced the appointment of Fernando Araujo as Chief…
-
1 month ago benzinga.com
TD Cowen Reiterates Buy on TransMedics Group, Maintains $120 Price Target
TD Cowen analyst Joshua Jennings reiterates TransMedics Group (NASDAQ:TMDX) with a Buy and maintains $120 price target.
-
2 months ago benzinga.com
UBS Maintains Neutral on TransMedics Group, Lowers Price Target to $77
UBS analyst Patrick Wood maintains TransMedics Group (NASDAQ:TMDX) with a Neutral and lowers the price target from $80 to $77.
-
2 months ago benzinga.com
Piper Sandler Reiterates Overweight on TransMedics Group, Lowers Price Target to $100
Piper Sandler analyst Matt O'Brien reiterates TransMedics Group (NASDAQ:TMDX) with a Overweight and lowers the price target from $120 to $100.
2 months ago benzinga.com
SpaceX, Teradata, Pinterest And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. stock futures mixed, Dow up 100 points. SpaceX stock falls 10.3% after reporting strong Q2 revenue but a loss. Other stocks also decline.
-
2 months ago benzinga.com
TransMedics Group Raises FY2026 Sales Guidance from $727.000M-$757.000M to $737.000M-$757.000M vs $732.700M Est
TransMedics Group (NASDAQ:TMDX) raises FY2026 sales outlook from $727.000 million-$757.000 million to $737.000 million-$757.000 million vs $732.700 million estimate.
-
2 months ago benzinga.com
TransMedics Gr Q2 Adj. EPS $0.44 Misses $0.47 Estimate, Sales $189.948M Beat $183.635M Estimate
TransMedics Gr (NASDAQ:TMDX) reported quarterly earnings of $0.44 per share which missed the analyst consensus estimate of $0.47 by 6.38 percent. This is a 52.17 percent decrease over earnings of…
-
3 months ago benzinga.com
Needham Maintains Buy on TransMedics Group, Lowers Price Target to $106
Needham analyst Mike Matson maintains TransMedics Group (NASDAQ:TMDX) with a Buy and lowers the price target from $142 to $106.
-
3 months ago benzinga.com
Evercore ISI Group Maintains Outperform on TransMedics Group, Lowers Price Target to $90
Evercore ISI Group analyst Daniel Markowitz maintains TransMedics Group (NASDAQ:TMDX) with a Outperform and lowers the price target from $100 to $90.
-
4 months ago benzinga.com
TD Cowen Reiterates Buy on TransMedics Group, Maintains $120 Price Target
TD Cowen analyst Joshua Jennings reiterates TransMedics Group (NASDAQ:TMDX) with a Buy and maintains $120 price target.
-
4 months ago benzinga.com
Stifel Maintains Hold on TransMedics Group, Raises Price Target to $80
Stifel analyst Tom Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and raises the price target from $75 to $80.
4 months ago benzinga.com
7 Health Care Stocks With Whale Alerts In Today's Session
7 Health Care Stocks With Whale Alerts In Today's Session
-
5 months ago benzinga.com
Stifel Maintains Hold on TransMedics Group, Lowers Price Target to $75
Stifel analyst Tom Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and lowers the price target from $85 to $75.
-
5 months ago benzinga.com
If You Invested $1000 In TransMedics Group Stock 5 Years Ago, You Would Have This Much Today
If You Invested $1000 In TransMedics Group Stock 5 Years Ago, You Would Have This Much Today
-
5 months ago benzinga.com
Canaccord Genuity Maintains Buy on TransMedics Group, Lowers Price Target to $124
Canaccord Genuity analyst William Plovanic maintains TransMedics Group (NASDAQ:TMDX) with a Buy and lowers the price target from $152 to $124.
-
5 months ago benzinga.com
TD Cowen Maintains Buy on TransMedics Group, Lowers Price Target to $120
TD Cowen analyst Joshua Jennings maintains TransMedics Group (NASDAQ:TMDX) with a Buy and lowers the price target from $190 to $120.
-
5 months ago benzinga.com
Stifel Maintains Hold on TransMedics Group, Lowers Price Target to $85
Stifel analyst Thomas Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and lowers the price target from $130 to $85.
5 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
-
6 months ago benzinga.com
Piper Sandler Maintains Overweight on TransMedics Group, Lowers Price Target to $120
Piper Sandler analyst Matt O'Brien maintains TransMedics Group (NASDAQ:TMDX) with a Overweight and lowers the price target from $160 to $120.
-
6 months ago benzinga.com
Needham Maintains Buy on TransMedics Group, Lowers Price Target to $142
Needham analyst Mike Matson maintains TransMedics Group (NASDAQ:TMDX) with a Buy and lowers the price target from $174 to $142.
6 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
6 months ago benzinga.com
Upstart Posts Downbeat Q1 Earnings, Joins Wolfspeed, Arista Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures up, Dow gains 200 points. Upstart (UPST) falls 11.8% on weak Q1 EPS and FY26 sales guidance. Other stocks also down in pre-market.
6 months ago benzinga.com
Why Veeco Instruments Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket
Veeco Instruments Inc (NASDAQ: VECO) rose in pre-market trading after reporting Q1 results and affirming FY26 sales guidance with midpoint above estimates. Other gainers include EZGO, EVC, GCTK,…
-
6 months ago benzinga.com
TransMedics Group Affirms FY2026 Sales Guidance of $727.000M-$757.000M vs $737.825M Est
TransMedics Group (NASDAQ:TMDX) affirms FY2026 sales outlook from $727.000 million-$757.000 million to $727.000 million-$757.000 million vs $737.825 million estimate.
-
6 months ago benzinga.com
TransMedics Gr Q1 Adj. EPS $0.30 Misses $0.61 Estimate, Sales $173.933M Beat $172.636M Estimate
TransMedics Gr (NASDAQ:TMDX) reported quarterly earnings of $0.30 per share which missed the analyst consensus estimate of $0.61 by 50.82 percent. This is a 59.46 percent decrease over earnings of…
-
6 months ago benzinga.com
TransMedics Announces Definitive Agreement To Invest In PAD Aviation To Develop Dedicated Organ Transplant Air And Ground Logistics Network In Europe; Terms Not Disclosed
The proposed strategic investment is subject to the satisfaction of closing conditions specified in the definitive agreement between the parties (the "Agreement") as well as applicable regulatory…
-
6 months ago benzinga.com
TransMedics Group To Unveil New Controlled, Active Cooling Preservation Device, Controlled Hypothermic Organ Preservation System At ISHLT 2026 Annual Meeting
Unveils New Controlled Hypothermic Organ Preservation System (CHOPS) to Expand its Product Portfolio and to Facilitate Enrollment in Control Arms of OCS ENHANCE Heart Part B and OCS DENOVO Lung…
6 months ago benzinga.com
Bears Pounce On Avis Budget, Lucid, MARA — Short Interest In These 10 Stocks Soars Above 40%
Choice Hotels, Avis Budget and Lucid stock all have short-interest above 50% of their free floats.
-
6 months ago benzinga.com
Evercore ISI Group Maintains Outperform on TransMedics Group, Lowers Price Target to $118
Evercore ISI Group analyst Daniel Markowitz maintains TransMedics Group (NASDAQ:TMDX) with a Outperform and lowers the price target from $170 to $118.
7 months ago benzinga.com
10 Health Care Stocks With Whale Alerts In Today's Session
10 Health Care Stocks With Whale Alerts In Today's Session
-
7 months ago benzinga.com
Stifel Maintains Hold on TransMedics Group, Raises Price Target to $130
Stifel analyst Thomas Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and raises the price target from $115 to $130.
-
8 months ago benzinga.com
JP Morgan Maintains Neutral on TransMedics Group, Raises Price Target to $149
JP Morgan analyst Allen Gong maintains TransMedics Group (NASDAQ:TMDX) with a Neutral and raises the price target from $114 to $149.
-
8 months ago benzinga.com
Oppenheimer Maintains Outperform on TransMedics Group, Raises Price Target to $175
Oppenheimer analyst Suraj Kalia maintains TransMedics Group (NASDAQ:TMDX) with a Outperform and raises the price target from $150 to $175.
-
8 months ago benzinga.com
Piper Sandler Maintains Overweight on TransMedics Group, Raises Price Target to $160
Piper Sandler analyst Matt O'Brien maintains TransMedics Group (NASDAQ:TMDX) with a Overweight and raises the price target from $140 to $160.
-
8 months ago benzinga.com
Evercore ISI Group Maintains Outperform on TransMedics Group, Raises Price Target to $170
Evercore ISI Group analyst Daniel Markowitz maintains TransMedics Group (NASDAQ:TMDX) with a Outperform and raises the price target from $155 to $170.
8 months ago benzinga.com
A Glimpse Into The Expert Outlook On TransMedics Group Through 4 Analysts
A Glimpse Into The Expert Outlook On TransMedics Group Through 4 Analysts
-
8 months ago benzinga.com
Needham Maintains Buy on TransMedics Group, Raises Price Target to $174
Needham analyst Mike Matson maintains TransMedics Group (NASDAQ:TMDX) with a Buy and raises the price target from $166 to $174.
8 months ago benzinga.com
Why Axon Enterprise Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Why Axon Enterprise Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
8 months ago benzinga.com
TransMedics Group Earnings Review: Q4 Summary
TransMedics Group Earnings Review: Q4 Summary
8 months ago benzinga.com
TransMedics Group Earnings Report: Q4 Overview
TransMedics Group Earnings Report: Q4 Overview
-
8 months ago benzinga.com
TransMedics Gr Q4 Adj. EPS $0.57 Beats $0.39 Estimate
TransMedics Gr (NASDAQ:TMDX) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $0.39 by 45.78 percent. This is a 200 percent increase over earnings of $0.19…
-
8 months ago benzinga.com
TransMedics Group Sees FY2026 Sales $727.000M-$757.000M vs $723.991M Est
TransMedics Group (NASDAQ:TMDX) sees FY2026 sales of $727.000 million-$757.000 million vs $723.991 million analyst estimate.
-
8 months ago benzinga.com
TransMedics Gr Q4 Sales $160.764M Beat $155.720M Estimate
TransMedics Gr (NASDAQ:TMDX) reported quarterly sales of $160.764 million which beat the analyst consensus estimate of $155.720 million by 3.24 percent. This is a 32.18 percent increase over sales of…